Drugs Made In America Acquisition Corp. · NASDAQ:DMAA
Drugs Made In America Acquisition Corp. shareholders
As of Jun 30, 2026, 23 institutions reported holding Drugs Made In America Acquisition Corp. Largest: Mizuho Securities USA LLC, Karpus Management, Inc. and Polar Asset Management Partners Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Drugs Made In America Acquisition Corp. | Change | Filed |
|---|---|---|---|---|
| Mizuho Securities USA LLC | 4.07M | +2.07M | Jul 28, 2026 | |
| Karpus Management, Inc. | 2.51M | −22,700 | Aug 14, 2026 | |
| Polar Asset Management Partners Inc. | 1.15M | −454K | Aug 14, 2026 | |
| Glazer Capital, LLC | 1000K | −679K | Aug 17, 2026 | |
| Wolverine Asset Management LLC | 832K | −722K | Aug 10, 2026 | |
| Highbridge Capital Management LLC | 809K | −514K | Aug 14, 2026 | |
| First Trust | 786K | −1.46M | Aug 13, 2026 | |
| Heights Capital Management, Inc | 648K | −1,917 | Aug 14, 2026 | |
| Westchester Capital Management, LLC | 582K | −1.09M | Aug 14, 2026 | |
| Clear Street Group Inc. | 382K | +28,392 | Aug 12, 2026 |